中國汽研(601965.SH):限制性股票激勵計劃(第二期)獲控股股東批覆
格隆匯1月13日丨中國汽研(601965.SH)公佈,公司第三屆董事會第二十二次會議審議通過了《關於的議案》及其相關議案,並於2019年12月31日披露了上述事項。
日前,公司收到控股股東中國通用技術(集團)控股有限責任公司(以下簡稱“中國通用技術集團”)印發的《關於中國汽車工程研究院股份有限公司實施第二期限制性股票激勵計劃的批覆》,中國通用技術集團原則同意公司實施第二期限制性股票激勵計劃,原則同意公司第二期限制性股票激勵計劃的業績考核目標。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.